NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line

Journal of the American Society of Nephrology

Volumn 10, Issue 11, 1999, Pages 2261-2271

  Ferguson, Shawn ^a   Hébert, Richard L ^a,b   Laneuville, Odette ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; RESVERATROL;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY COLLECTING TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

EID: 0344131879     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. DeWitt D, Smith WL: Yes, but do they still get headaches? Cell 83: 345-348, 1995
2. Smith WL, Laneuville O: Cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism. In: Eicosanoids and Their Inhibitors in Cancer Immunology and Immunotherapy, edited by Anderson KM, Harris J, Boca Raton, FL, CRC Press, 1994, pp 1-39
3. Bonvalet JP, Pradelles P, Farman N: Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol 253: F377-F387, 1987
4. Breyer MD, Zhang YH, Guan YF, Hao CM, Hébert RL, Breyer RM: Regulation of renal function by prostaglandin E receptors. Kidney Int 67[Suppl]: S88-S94, 1998
5. Zambraski EJ: The effects of nonsteroidal anti-inflammatory drugs on renal function: Experimental studies in animals. Semin Nephrol 15: 205-213, 1995
6. Bennet WM, Henrich WL, Stoff JS: The renal effects of nonsteroidal anti-inflammatory drugs: Summary and recommendations. Am J Kidney Dis 28: S56-S62, 1996
7. Patrono C, Alessandro P: Renal effects of nonsteroidal anti-inflammatory drugs in chronic glomerular disease. Am J Med 81: 71-83, 1986
8. Schneider A, Stahl RA: Cyclooxygenase-2 and the kidney: Current status and potential perspectives. Nephrol Dial Transplant 13: 10-12, 1998
9. Murray MD, Brater CD: Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu Rev Toxicol 32: 435-465, 1993
10. Schramek H, Coroneos E, Dunn M: Interactions of the vasoconstrictor peptides, angiotensin II and endothelin-I, with vasodilatory prostaglandins. Semin Nephrol 15: 195-204, 1995
11. Harris RC, Wang JL, Cheng HF, Zhang MZ, McKanna JA: Prostaglandins in macula densa function. Kidney Int 54[Suppl]: S49-S52, 1998
12. Smith WL, Garavito M, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157-33160, 1996
13. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA: Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049-9054, 1993
14. Kujubu DA, Reddy ST, Fletcher BS, Herschman HR: Expression of the protein product of the prostaglandin synthase-2/TIS 10 gene in mitogen-stimulated Swiss 3T3 cells. J Biol Chem 268: 5425-5432, 1993
15. DeWitt DL, Meade EA: Serum and glucocorticoid regulation of gene transcription and expression the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch Biochem Biophys 326: 94-104, 1993
16. Evett GE, Xie W, Chipman JG, Robertson DL, Simmons DL: Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: Regulation by dexamethasone, mitogens, and oncogenes. Arch Biochem Biophys 326: 169-177, 1993
17. Laneuville O, Breuer DK, DeWitt DL, Hla T, Funk CD, Smith WL: Differential inhibition of human prostaglandin endoperoxide H synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 271: 927-934, 1994
18. Futaki N, Yoshikawa K, Hamasaka Y, Arai I, Higuchi S, Iizuka, Otomo S: NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 24: 105-110, 1993
19. Pennisi E: Building a better aspirin. Science 280: 1191-1192, 1998
20. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, Smithies O: Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483-492, 1995
21. Morham SG, Langenbach R, Loftin CD, Tiano HF, Voulomanos N. Jennette CJ, Ledford A, Lee CA, Smithies O: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473-482, 1995
22. Harris RC, McKanna JA, Akai Y, Jacobson HR, DuBois RN, Breyer MD: Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin Invest 94: 2504-2510, 1994
23. Vio CP, Cespedes C, Gallardo P, Masferrer JL: Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 32: 687-692, 1997
24. Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, Briggs JP: Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol 274: F481-F489, 1998
25. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, Carretero OA: Cyclooxygenase-2 mediates increased renal renin content by low-sodium diet. Hypertension 29[Part 2]: 297-302, 1997
26. Stoos BA, Naray-Fejes-Toth A, Carretero OA, Ito S, Fejes-Toth G: Characterization of a mouse cortical collecting duct cell line. Kidney Int 39: 1168-1175, 1991
27. Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen S, Tsing C, Bach J, Friere H, Chan E, Ramesha C: Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta 1209: 132-139, 1994
28. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Siebert K: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91: 3228-3232, 1994
29. Jung M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn D, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventative activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997
30. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S: Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 361: 549-552, 1993
31. Marples D, Knepper MA, Christensen EI, Nielson S: Resdistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct: Am J Physiol 269: C655-C664, 1995
32. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt D, Smith WL: Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270: 10902-10908, 1995
33. Smith WL, Bell TG: Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol 235: F451-F470, 1978
34. Kömhoff M, Gröne HJ, Klein T, Seyberth HJ, Nüsing RM: Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function. Am J Physiol 272: F460-F468, 1997
35. Hartner A, Goppelt-Struebe M, Hilgers KF: Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension 31 [Part 2]: 201-205, 1998
36. Coleman RA, Smith WL, Narumiya S: VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994
37. Breyer M, Davis L, Jacobson H, Breyer R: Differential localization of prostaglandin E receptor subtypes in human kidney. Am J Physiol 210: F912-F918, 1996
38. Chulada PC, Langenbach R: Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 280: 606-613, 1997
39. Kirtihara K, Morham SG, Raghow R, Laulederkind SJF, Kanekura T, Goorha S, Ballou LR: Compensatory prostaglandin biosynthesis in cyclooxygenase 1 or 2 null cells. J Exp Med 187: 517-523, 1998
40. Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T: Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. J Biol Chem 270: 24965-24971, 1995
41. Ristimäki A, Garfinkel S, Wessendorf J, Maciag T, Hla T: Induction of cyclooxygenase-2 by interleukin-1α. J Biol Chem 269: 11769-11775, 1994
42. 2 generation in mouse osteoblastic cells. J Biol Chem 272: 19891-19897, 1997
43. 2 inhibits AVP-induced water flow in cortical collecting duct by protein kinase C activation. Am J Physiol 259: F318-F325, 1990